A Multicenter, Open-label, Non-comparative Phase IV Clinical Study to Evaluate the Safety and Clinical Efficacy of Augmentin Extra Strength (ES)-600 in Children With Acute Otitis Media (AOM) in India
Latest Information Update: 13 Jun 2024
At a glance
- Drugs Amoxicillin/clavulanic acid (Primary)
- Indications Otitis media
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 30 Nov 2022 Status changed from recruiting to completed.
- 19 Apr 2022 Planned End Date changed from 10 Jun 2022 to 1 Dec 2022.
- 19 Apr 2022 Planned primary completion date changed from 31 Mar 2022 to 1 Dec 2022.